What are the signs and symptoms of CKD?

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

Chronic Kidney Disease (CKD) progresses slowly and may remain asymptomatic in its early stages. However, as the disease advances, symptoms become more apparent. Here are the common signs and symptoms of CKD, categorized by the stages and severity of the disease:

Early-Stage CKD (Stages 1 and 2)

In the early stages, CKD often has no symptoms. It is usually detected through blood and urine tests performed for other reasons.

Moderate to Advanced CKD (Stages 3 to 5)

As CKD progresses, symptoms become more noticeable. These symptoms can include:

Changes in Urination:
- Increased Frequency: Needing to urinate more often, especially at night (nocturia).
- Decreased Frequency: Less frequent urination or urine output.
- Foamy Urine: Presence of bubbles in the urine due to excess protein (proteinuria).
- Blood in Urine: Hematuria, which can cause urine to appear red or tea-colored (World Health Organization (WHO)) (World Health Organization (WHO)).
Swelling (Edema):
- Swelling in the legs, ankles, feet, and sometimes the hands and face due to fluid retention (World Health Organization (WHO)) (Nature).
Fatigue:
- Persistent tiredness and lack of energy due to the buildup of toxins and impurities in the blood, which can also cause anemia (World Health Organization (WHO)).
Shortness of Breath:
- Difficulty breathing due to fluid buildup in the lungs (pulmonary edema) or anemia (Nature) (IHCI).
Skin Changes:
- Dry, itchy skin due to imbalances in minerals and nutrients, which the kidneys usually regulate.
- Darkening of the skin, especially around the eyes and in the folds of the skin, can occur in advanced stages (World Health Organization (WHO)) (World Health Organization (WHO)).
Muscle Cramps and Twitching:
- Electrolyte imbalances, particularly low calcium levels, can cause muscle cramps and twitching (Nature).
Nausea and Vomiting:
- The buildup of waste products in the blood can lead to gastrointestinal symptoms, including nausea and vomiting (World Health Organization (WHO)).
Loss of Appetite and Weight Loss:
- Reduced appetite and weight loss due to nausea and general ill-feeling (World Health Organization (WHO)) (IHCI).
Metallic Taste in Mouth and Ammonia Breath:
- Waste buildup can cause a metallic taste in the mouth and bad breath that smells like ammonia (Nature) (World Health Organization (WHO)).
High Blood Pressure:
- Elevated blood pressure that is difficult to control, contributing to further kidney damage (World Health Organization (WHO)) (IHCI).

Advanced Symptoms (Stage 5 or End-Stage Renal Disease)

In the most severe stage of CKD, symptoms can become life-threatening, including:

Severe Fluid Retention:
- Extensive swelling and shortness of breath due to fluid overload.
Severe Anemia:
- Extreme fatigue and weakness due to reduced production of erythropoietin, which stimulates red blood cell production (IHCI).
Bone Pain and Fractures:
- Weakened bones and an increased risk of fractures due to imbalances in calcium and phosphorus (World Health Organization (WHO)) (Nature).
Cognitive Impairment:
- Difficulty concentrating and memory problems due to the buildup of toxins in the brain (uremic encephalopathy) (World Health Organization (WHO)) (IHCI).

Conclusion

CKD can present a range of symptoms that worsen as the disease progresses. Early detection through routine screening, especially for those at risk, is crucial to manage and slow the progression of CKD. Recognizing the symptoms early can lead to better management and improved outcomes for individuals with CKD.

References

How is the severity of CKD assessed in India?

The severity of Chronic Kidney Disease (CKD) in India, as elsewhere, is assessed using a combination of clinical evaluations, laboratory tests, imaging studies, and assessment of risk factors. The key components used to determine the severity of CKD include the estimation of Glomerular Filtration Rate (eGFR), the presence of proteinuria, and the detection of complications related to kidney damage. Here’s a detailed overview of the assessment process:

Staging of CKD

The severity of CKD is categorized into five stages based on the eGFR, which measures how well the kidneys filter blood. This classification helps in understanding the extent of kidney damage and guiding treatment.

Stage 1 (GFR ≥ 90 mL/min/1.73 m²):
- Description: Normal or increased GFR with evidence of kidney damage (e.g., proteinuria, hematuria, structural abnormalities).
- Management: Address underlying conditions, lifestyle modifications, and regular monitoring.
Stage 2 (GFR 60-89 mL/min/1.73 m²):
- Description: Mild decrease in GFR with kidney damage.
- Management: Similar to Stage 1, with emphasis on controlling risk factors and regular monitoring.
Stage 3 (GFR 30-59 mL/min/1.73 m²):
- Description: Moderate decrease in GFR.
- Management: Intensive management of underlying conditions, dietary modifications, and treatment of complications like anemia and bone disease. Regular follow-ups are crucial.
Stage 4 (GFR 15-29 mL/min/1.73 m²):
- Description: Severe decrease in GFR.
- Management: Preparation for potential kidney replacement therapy (dialysis or transplant), and management of symptoms and complications. Referral to a nephrologist is essential.
Stage 5 (GFR < 15 mL/min/1.73 m²):
- Description: End-stage renal disease (ESRD).
- Management: Dialysis or kidney transplant required. Intensive management of symptoms and complications.

Key Diagnostic Tests

eGFR (Estimated Glomerular Filtration Rate):
- Calculation: eGFR is calculated based on serum creatinine levels, age, gender, and body size. It provides an estimate of kidney function.
- Usage: Determines the stage of CKD and helps in monitoring progression (World Health Organization (WHO)) (Nature).
Proteinuria Testing:
- Urinalysis: Detects protein, blood, and other abnormalities in the urine.
- Urine Albumin-to-Creatinine Ratio (UACR): Measures the amount of albumin relative to creatinine in the urine. Persistent proteinuria is a sign of kidney damage.
- 24-hour Urine Collection: Measures the total amount of protein excreted in urine over 24 hours (Nature) (World Health Organization (WHO)).
Blood Tests:
- Serum Creatinine: Measures creatinine levels in the blood. Elevated levels indicate reduced kidney function.
- Blood Urea Nitrogen (BUN): Measures the amount of nitrogen in the blood from urea. Higher levels suggest impaired kidney function.
- Electrolytes and Blood Chemistry: Assess levels of sodium, potassium, calcium, phosphorus, and other key elements to detect imbalances (World Health Organization (WHO)) (IHCI).

Imaging and Additional Assessments

Renal Ultrasound:
- Purpose: Provides images of the kidneys to detect structural abnormalities, obstructions, cysts, and size changes.
- Usage: Helps in identifying the cause of CKD and assessing the extent of damage (World Health Organization (WHO)) (IHCI).
CT Scan and MRI:
- Purpose: Detailed imaging to identify stones, tumors, or other abnormalities affecting the kidneys.
- Usage: Used when ultrasound findings are inconclusive or when more detailed images are required (Nature).
Kidney Biopsy:
- Purpose: Involves taking a small sample of kidney tissue for microscopic examination.
- Usage: Helps determine the type and extent of kidney damage, especially when the cause of CKD is unclear (IHCI).

Risk Factor Assessment

Diabetes and Hypertension Screening:
- Regular monitoring and management of diabetes and hypertension, which are major risk factors for CKD (Nature).
Lipid Profile:
- Measures cholesterol and triglycerides in the blood to assess cardiovascular risk, often elevated in CKD patients (World Health Organization (WHO)).

Conclusion

Assessing the severity of CKD in India involves a comprehensive approach, combining clinical evaluations, laboratory tests, imaging studies, and risk factor assessments. Early detection and effective management are crucial to slow the progression of CKD and improve patient outcomes.